Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Proveda Corporation holds a company patent portfolio within the Biotechnology & Pharmaceuticals technology area. Currently, the portfolio includes 1 pending office action. This action is being processed in 1 distinct art unit, indicating a specific area of focus for the company's current intellectual property development. The singular pending action suggests a targeted approach to securing patent rights in the pharmaceutical sector.
The examination is handled by 1 distinct examiner, KETCHAM, KAREN A. As the busiest examiner, KETCHAM, KAREN A is managing 1 pending office action. This single action represents the entirety of the company's current active prosecution. The alignment of 1 pending office action with 1 distinct examiner and 1 distinct art unit means that the company's immediate patenting outcomes are tied to the review and feedback of this individual examiner. For a practitioner, this requires a focused strategy to address the specific requirements of KETCHAM, KAREN A within the designated art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KETCHAM, KAREN A | 1 | 20.0% | +38.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18307253 | TOPICAL FORMULATIONS | KETCHAM, KAREN A | 139d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18307253 | TOPICAL FORMULATIONS | KETCHAM, KAREN A | 139d overdue |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18307253 | TOPICAL FORMULATIONS | KETCHAM, KAREN A | 1614 | §103 | Final Rejection | 139d overdue | Pending | Apr 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial